These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28560673)

  • 1. Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.
    Kanwar N; Done SJ
    Adv Exp Med Biol; 2017; 994():143-167. PubMed ID: 28560673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY; Chang YC
    Adv Exp Med Biol; 2017; 994():43-66. PubMed ID: 28560667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of genomic signatures in circulating tumor cells from breast cancer.
    Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
    Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
    Chen S; El-Heliebi A; Kroneis T
    Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.
    Cho WJ; Oliveira DS; Najy AJ; Mainetti LE; Aoun HD; Cher ML; Heath E; Kim HR; Bonfil RD
    J Transl Med; 2016 Mar; 14():72. PubMed ID: 26975354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype.
    Wang H; Wu X
    Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells in Breast Cancer Patients.
    Hall C; Valad L; Lucci A
    Crit Rev Oncog; 2016; 21(1-2):125-39. PubMed ID: 27481009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer.
    Marín-Aguilera M; Reig Ò; Lozano JJ; Jiménez N; García-Recio S; Erill N; Gaba L; Tagliapietra A; Ortega V; Carrera G; Colomer A; Gascón P; Mellado B
    Oncotarget; 2015 Apr; 6(12):10604-16. PubMed ID: 25871394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signatures of breast cancer metastasis at a glance.
    Karagiannis GS; Goswami S; Jones JG; Oktay MH; Condeelis JS
    J Cell Sci; 2016 May; 129(9):1751-8. PubMed ID: 27084578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
    Joosse SA; Pantel K
    Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample-to-Answer Isolation and mRNA Profiling of Circulating Tumor Cells.
    Mohamadi RM; Ivanov I; Stojcic J; Nam RK; Sargent EH; Kelley SO
    Anal Chem; 2015 Jun; 87(12):6258-64. PubMed ID: 26009151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration.
    Hwang WL; Pleskow HM; Miyamoto DT
    Adv Drug Deliv Rev; 2018 Feb; 125():122-131. PubMed ID: 29326053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.